Dosage dependent genes such as MECP2, where mutations cause Rett syndrome (Amir et al., 1999), and the dominant-negative expression of the FBN1 gene in Marfan syndrome (Robinson and Godfrey, 2000) are prime examples where gene transfer therapies are ambitious. Here, FBN1 is linked to atypical Rett syndrome.